Black Diamond Therapeutics, Inc. (BDTX) vs Lucid Diagnostics Inc. (LUCD)
A side-by-side comparison of Black Diamond Therapeutics, Inc. and Lucid Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDTX
Black Diamond Therapeutics, Inc.
$1.89HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
LUCD
Lucid Diagnostics Inc.
$0.61HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — BDTX vs LUCD
growth of $100 · dividends reinvested · last 5yBDTX -76.3% (-25.0%/yr)LUCD -95.0% (-45.0%/yr)BDTX compounded faster over this window
BDTX LUCD
BDTX vs LUCD: by the numbers
- •LUCD is the larger company ($116M vs $108M market cap).
- •BDTX is profitable (31.95% net margin) while LUCD runs a net loss (-959.76%).
Metrics side by side
Valuation
| Metric | BDTX | LUCD |
|---|---|---|
| P/S ratio | N/A | 21.23 |
| P/B ratio | 1.12 | 10.58 |
Profitability
| Metric | BDTX | LUCD |
|---|---|---|
| Gross margin | 99.54% | -60.26% |
| Operating margin | 28.39% | -1054.82% |
| Net margin | 31.95% | -959.76% |
| ROE | -44.29% | -478.26% |
| ROIC | -47.54% | -145.10% |
Growth (annualized)
| Metric | BDTX | LUCD |
|---|---|---|
| Total return CAGR (5Y) | -24.47% | N/A |
Frequently asked
- Is BDTX or LUCD more profitable?
- BDTX runs the higher net margin — BDTX at 31.95% versus LUCD at -959.76%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.